Clinical Trials for Gastric Cancer

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT ID: NCT05891171

This clinical trial is studying a new treatment called AB598 for patients with advanced cancers, including types like bladder, cervical, lung, and breast cancer, among others. The main goal is to s...

Early Detection and Post-operative Monitoring of Gastric Cancer

NCT ID: NCT06232395

This clinical trial is focused on finding better ways to detect gastric cancer (a type of stomach cancer) early and to monitor patients after surgery. Researchers are testing new, non-invasive test...

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

NCT ID: NCT06219941

This clinical trial is studying a new treatment called AZD0901 for patients with advanced solid tumors that express a protein known as Claudin18.2. The trial aims to find out how safe and effective...

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT ID: NCT05208762

This clinical trial is studying a new drug called PF-08046054/SGN-PDL1V to see how safe it is for patients with advanced solid tumors, which are cancers that have spread in the body or cannot be su...

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

NCT ID: NCT07001592

This clinical trial is studying a new experimental treatment called vvDD-hIL2, which is being tested for patients with advanced abdominal cancers, such as gastric and liver cancer. The goal of the ...

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

NCT ID: NCT06413212

This clinical trial is looking at a new way to find the most effective treatments for patients with advanced cancers, such as lung, breast, gastric, and colorectal cancer, who are experiencing flui...

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

NCT ID: NCT06346392

This clinical trial is studying a new treatment called AZD0901 for patients with advanced or metastatic gastric cancer or gastroesophageal junction cancer that expresses a specific protein known as...

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT ID: NCT06293898

This clinical trial is studying a new treatment called BL-M07D1 for patients with certain types of advanced cancers that have a protein called HER2. The goal is to find out if this treatment is saf...

Phase 1 Open-Label Study BL-M17D1 w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT ID: NCT06714617

This clinical trial is investigating a new treatment called BL-M17D1 for patients with advanced or metastatic solid tumors that have a specific protein called HER2. The study aims to evaluate how s...

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

NCT ID: NCT05489211

The TROPION-PanTumor03 clinical trial is exploring a new treatment called Datopotamab Deruxtecan (Dato-DXd) for patients with advanced solid tumors, including types of cancer like endometrial, gast...

Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms

NCT ID: NCT06078930

This clinical trial is investigating new ways to detect gastric cancer by looking at images of the tongue and studying changes in the tongue’s appearance. The researchers aim to gather information ...

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT ID: NCT06695845

This clinical trial is studying a new treatment called zanidatamab for patients with certain types of solid tumors that have high levels of a protein called HER2. These tumors include breast, gastr...

A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China

NCT ID: NCT06585501

Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers

NCT ID: NCT05205330

This clinical trial is investigating the combination of two drugs, CR6086 and AGEN2034, for patients with advanced colorectal cancer that is difficult to treat, as well as other metastatic gastroin...

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

NCT ID: NCT06532006

This clinical trial is studying a new treatment for patients with HER2-positive gastric cancer or gastroesophageal junction cancer. The treatment combines a drug called HLX22 with trastuzumab and c...

Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer

NCT ID: NCT05652348

This clinical trial is exploring a treatment approach for patients with gastric or colon cancer that has spread to the lining of the abdomen, a condition known as peritoneal carcinomatosis. During ...

OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method

NCT ID: NCT05450835

This clinical trial, called CLASS15-01, is studying a new surgical method called OGT-assisted overlap esophagojejunostomy in comparison to a traditional surgical method for patients with gastric ca...

Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore

NCT ID: NCT06157996

This clinical trial is studying a new combination treatment for adults with advanced gastric cancer or gastroesophageal junction adenocarcinoma, specifically for those whose tumors are positive for...

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

NCT ID: NCT06988475

The DETERMINE Trial is researching a medication called capmatinib, which is typically used to treat certain types of lung cancer. This study aims to see if capmatinib can also help adults with othe...

GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites

NCT ID: NCT05438459

The GAIA-102 clinical trial is studying a new treatment for patients with advanced gastric or pancreatic cancer, specifically for those who have a type of cancer that does not respond to traditiona...